ES2076085B1 - ANGIOTENSIN II ANTAGONISTS. - Google Patents

ANGIOTENSIN II ANTAGONISTS.

Info

Publication number
ES2076085B1
ES2076085B1 ES9301321A ES9301321A ES2076085B1 ES 2076085 B1 ES2076085 B1 ES 2076085B1 ES 9301321 A ES9301321 A ES 9301321A ES 9301321 A ES9301321 A ES 9301321A ES 2076085 B1 ES2076085 B1 ES 2076085B1
Authority
ES
Spain
Prior art keywords
angiotensin
antagonists
formula
provides
famaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9301321A
Other languages
Spanish (es)
Other versions
ES2076085A1 (en
Inventor
Donald Bradford Boyd
Kenneth Lee Hauser
Sherryl Lynn Lifer
Winston Stanley Marshall
Alan David Palkowitz
William Pfeifer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to ES9301321A priority Critical patent/ES2076085B1/en
Publication of ES2076085A1 publication Critical patent/ES2076085A1/en
Application granted granted Critical
Publication of ES2076085B1 publication Critical patent/ES2076085B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

ANTAGONISTAS DE ANGIOTENSINA II. LA INVENCION PROPORCIONA COMPUESTOS DE FORMULA (I) QUE ANTAGONIZA LA ANGIOTENSINA II EN LOS SITIOS RECEPTORES DEL CUERPO. TAMBIEN PROPORCIONA FORMULACIONES FARMACEUTICAS QUE COMPRENDEN UN COMPUESTO DE FORMULA I JUNTO CON UNO O MAS EXCIPIENTES ACEPTABLES FAMACEUTICAMENTE, VEHICULOS O DILUYENTES. TIENE APLICACION EN EL TRATAMIENTO DE LA HIPERTENSION, FALLO CARDIACO CONGESTIVO, INSUFICIENCIAS RENALES Y GLAUCOMA, ASI COMO EN LA MEJORA DEL RENDIMIENTO COGNITIVO.ANGIOTENSIN II ANTAGONISTS. THE INVENTION PROVIDES FORMULA (I) COMPOUNDS THAT ANTAGONIZE ANGIOTENSIN II IN THE RECEPTION SITES OF THE BODY. IT ALSO PROVIDES PHARMACEUTICAL FORMULATIONS INCLUDING A COMPOUND OF FORMULA I TOGETHER WITH ONE OR MORE FAMACEUTICALLY ACCEPTABLE EXCIPIENTS, VEHICLES OR THINNERS. IT HAS APPLICATION IN THE TREATMENT OF HYPERTENSION, CONGESTIVE CARDIAC FAILURE, RENAL FAILURE AND GLAUCOMA, AS WELL AS IN IMPROVING COGNITIVE PERFORMANCE.

ES9301321A 1993-06-15 1993-06-15 ANGIOTENSIN II ANTAGONISTS. Expired - Fee Related ES2076085B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301321A ES2076085B1 (en) 1993-06-15 1993-06-15 ANGIOTENSIN II ANTAGONISTS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301321A ES2076085B1 (en) 1993-06-15 1993-06-15 ANGIOTENSIN II ANTAGONISTS.

Publications (2)

Publication Number Publication Date
ES2076085A1 ES2076085A1 (en) 1995-10-16
ES2076085B1 true ES2076085B1 (en) 1997-03-01

Family

ID=8282194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301321A Expired - Fee Related ES2076085B1 (en) 1993-06-15 1993-06-15 ANGIOTENSIN II ANTAGONISTS.

Country Status (1)

Country Link
ES (1) ES2076085B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (en) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim NEW SUBSTITUTED 2-PHENYLAMINOIMIDAZOLINE- (2), THEIR ACID-ADDITIONAL SALTS AND PROCESS FOR THEIR PRODUCTION
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists

Also Published As

Publication number Publication date
ES2076085A1 (en) 1995-10-16

Similar Documents

Publication Publication Date Title
PT94568A (en) SUBSTITUTED CHINAZOLINONES AS ANGIOTENSIN II ANTAGONISTS
LV12639B (en) Biphenylsulfonamide is a dual angiotensin and endothelin receptor antagonist
EA200301142A1 (en) DERIVATIVES OF HETEROCYCLILOXY-, -TIOOXY-AND-AMINOBENZAZOL AS A LYHANDS OF 5-HYDROXITRIPTAMINE-6
DE60214392D1 (en) 1,4-DISUBSTITUTED BENZO-CONDENSED CYCLOALKYL UREA COMPOUNDS
EA199800913A1 (en) CALCYLYTIC COMPOUNDS
AR034709A1 (en) A PROCEDURE FOR THE TELOMERIZATION OF ACICLIC OLEFINS.
MY126559A (en) Fungicidal 2-methoxybenzophenones
UY26482A1 (en) BIPHENYL SULPHONAMIDES AS ANGIOTENSIN RECEPTOR ANTAGONISTS
EA200101177A1 (en) INDOL DERIVATIVES AS PROGESTERONE ANTAGONISTS
BR0112030A (en) New compounds that have antibacterial, antifungal or antitumor activity
GT199900070A (en) DERIVATIVES OF ISOTIAZOLE, USEFUL AS ANTI-CANCER AGENTS.
DE69930328D1 (en) Dimer pyrrolobenzodiazepines
PA8556701A1 (en) DERIVATIVES OF 3-AZABICICLO (3.1.0) HEXANO
EA200300716A1 (en) HETEROCYCLILALKILINDOL OR-ASAINDOL COMPOUNDS AS LIGAND 5-HYDROXYTRIPTAMINE-6
ATE225349T1 (en) CRF RECEPTOR ANTAGONISTS AND RELATED METHODS
EA200001039A1 (en) CALCYLYTIC COMPOUNDS
EA200301143A1 (en) DERIVATIVES OF HETEROCYCLILALKOXY-, ALKYLTIO-AND-ALKYLAMINOBENZENOLE AS 5-HYDROXITRIPTAMINE-6 LIGANDS
CO4750755A1 (en) SYNERGIC MIXTURE OF AN ARYL OR HETEROARIL COMPOUND THAT INHIBITS THE BREATHING OF THE CYTOCHROME COMPLEX AND 4-TERT-BUTYLPHENYLQUINAZOLIN-4IL ETER
ES2175328T3 (en) PIPERIDONAS AS ANTAGONISTS OF TAQUIQUININA.
EA200201158A1 (en) BICYCLIC CYCLOGEXYLAMINES AND THEIR APPLICATION AS ANTAGONISTS OF NMDA RECEPTORS
DE60112574D1 (en) BICYCLIC CYCLOHEXYLAMINES AND THEIR USE AS NMDA RECEPTOR ANTAGONISTS
ES2171911T3 (en) CONFORMATIONALLY RESTRICTED POLYAMINS AND ITS USE AS ANTINEOPLASIC AGENTS.
ES2152328T3 (en) ANTIGONISTS OF THE FIBRINOGEN RECEIVER.
ES2100689T3 (en) SYNERGIZING ASSOCIATION THAT HAS AN ANTAGONIST EFFECT ON NK1 AND NK2 RECEPTORS.
ATE497967T1 (en) INTERCELLULAR COMMUNICATION FACILITATING COMPOUNDS AND THEIR MEDICAL USES

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930615

Kind code of ref document: B1

Effective date: 19930615

FD1A Patent lapsed

Effective date: 20040503